{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T01:54:52Z","timestamp":1767923692572,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,1,4]],"date-time":"2013-01-04T00:00:00Z","timestamp":1357257600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2407-13-7","type":"journal-article","created":{"date-parts":[[2013,1,4]],"date-time":"2013-01-04T03:14:16Z","timestamp":1357269256000},"source":"Crossref","is-referenced-by-count":34,"title":["Benign prostatic hyperplasia is a significant risk factor for bladder cancer in diabetic patients: a population-based cohort study using the National Health Insurance in Taiwan"],"prefix":"10.1186","volume":"13","author":[{"given":"Chin-Hsiao","family":"Tseng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,4]]},"reference":[{"issue":"5 Suppl","key":"3595_CR1","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1016\/j.juro.2008.03.141","volume":"179","author":"JT Wei","year":"2008","unstructured":"Wei JT, Calhoun E, Jacobsen SJ: Urologic diseases in America project: benign prostatic hyperplasia. J Urol. 2008, 179 (5 Suppl): S75-S80.","journal-title":"J Urol"},{"key":"3595_CR2","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1464-410X.2011.10283.x","volume":"109","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Zhu C, Curado MP, Zheng T, Boyle P: Changing patterns of bladder cancer in the USA: evidence of heterogeneous disease. BJU Int. 2012, 109: 52-56.","journal-title":"BJU Int"},{"key":"3595_CR3","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s11884-010-0067-2","volume":"5","author":"JK Parsons","year":"2010","unstructured":"Parsons JK: Benign prostatic hyperplasia and male lower urinary tract symptoms: epidemiology and risk factors. Curr Bladder Dysfunct Rep. 2010, 5: 212-218. 10.1007\/s11884-010-0067-2.","journal-title":"Curr Bladder Dysfunct Rep"},{"key":"3595_CR4","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1111\/j.1464-410X.2008.08261.x","volume":"103","author":"S Matsumoto","year":"2009","unstructured":"Matsumoto S, Shimizu N, Hanai T, Uemura H, Levin R: Bladder outlet obstruction accelerates bladder carcinogenesis. BJU Int. 2009, 103: 1436-1439. 10.1111\/j.1464-410X.2008.08261.x.","journal-title":"BJU Int"},{"key":"3595_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/BF00256946","volume":"11","author":"S Mommsen","year":"1983","unstructured":"Mommsen S, Sell A: Prostatic hypertrophy and venereal disease as possible risk factors in the development of bladder cancer. Urol Res. 1983, 11: 49-52.","journal-title":"Urol Res"},{"key":"3595_CR6","first-page":"969","volume":"41","author":"S Nakata","year":"1995","unstructured":"Nakata S, Sato J, Ohtake N, Imai K, Yamanaka H: Epidemiological study of risk factors for bladder cancer. Hinyokika Kiyo. 1995, 41: 969-977. Japanese","journal-title":"Hinyokika Kiyo"},{"key":"3595_CR7","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/sj.bjc.6603730","volume":"96","author":"D Kang","year":"2007","unstructured":"Kang D, Chokkalingam AP, Gridley G, Nyren O, Johansson JE, Adami HO, Silverman D, Hsing AW: Benign prostatic hyperplasia and subsequent risk of bladder cancer. Br J Cancer. 2007, 96: 1475-1479. 10.1038\/sj.bjc.6603730.","journal-title":"Br J Cancer"},{"key":"3595_CR8","doi-asserted-by":"publisher","first-page":"476","DOI":"10.2337\/dc07-1148","volume":"31","author":"AV Sarma","year":"2008","unstructured":"Sarma AV, Burke JP, Jacobson DJ, McGree ME, St Sauver J, Girman CJ, Lieber MM, Herman W, Macoska J, Montie JE, Jacobsen SJ: Associations between diabetes and clinical markers of benign prostatic hyperplasia among community-dwelling Black and White men. Diabetes Care. 2008, 31: 476-482.","journal-title":"Diabetes Care"},{"key":"3595_CR9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.urology.2011.08.065","volume":"79","author":"AV Sarma","year":"2012","unstructured":"Sarma AV, St Sauver JL, Hollingsworth JM, Jacobson DJ, McGree ME, Dunn RL, Lieber MM, Jacobsen SJ, Urologic Diseases in America Project: Diabetes treatment and progression of benign prostatic hyperplasia in community-dwelling black and white men. Urology. 2012, 79: 102-108. 10.1016\/j.urology.2011.08.065.","journal-title":"Urology"},{"key":"3595_CR10","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/S0022-5347(05)67529-5","volume":"163","author":"MC Michel","year":"2000","unstructured":"Michel MC, Mehlburger L, Schumacher H, Bressel HU, Goepel M: Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasia. J Urol. 2000, 163: 1725-1729. 10.1016\/S0022-5347(05)67529-5.","journal-title":"J Urol"},{"key":"3595_CR11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s11934-001-0067-z","volume":"2","author":"TA Boon","year":"2001","unstructured":"Boon TA, Van Venrooij GE, Eckhardt MD: Effect of diabetes mellitus on lower urinary tract symptoms and dysfunction in patients with benign prostatic hyperplasia. Curr Urol Rep. 2001, 2: 297-301. 10.1007\/s11934-001-0067-z.","journal-title":"Curr Urol Rep"},{"issue":"6 Suppl","key":"3595_CR12","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1016\/j.juro.2009.07.088","volume":"182","author":"AV Sarma","year":"2009","unstructured":"Sarma AV, Parsons JK, McVary K, Wei JT: Diabetes and benign prostatic hyperplasia\/lower urinary tract symptoms\u2013what do we know?. J Urol. 2009, 182 (6 Suppl): S32-S37.","journal-title":"J Urol"},{"key":"3595_CR13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.urology.2005.08.010","volume":"67","author":"JP Burke","year":"2006","unstructured":"Burke JP, Jacobson DJ, McGree ME, Roberts RO, Girman CJ, Lieber MM, Jacobsen SJ: Diabetes and benign prostatic hyperplasia progression in Olmsted County Minnesota. Urology. 2006, 67: 22-25. 10.1016\/j.urology.2005.08.010.","journal-title":"Urology"},{"key":"3595_CR14","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1210\/jc.2005-2799","volume":"91","author":"JK Parsons","year":"2006","unstructured":"Parsons JK, Carter HB, Partin AW, Windham BG, Metter EJ, Ferrucci L, Landis P, Platz EA: Metabolic factors associated with benign prostatic hyperplasia. J Clin Endocrinol Metab. 2006, 91: 2562-2568. 10.1210\/jc.2005-2799.","journal-title":"J Clin Endocrinol Metab"},{"key":"3595_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MOU.0b013e32834100c9","volume":"21","author":"JK Parsons","year":"2011","unstructured":"Parsons JK: Lifestyle factors, benign prostatic hyperplasia, and lower urinary tract symptoms. Curr Opin Urol. 2011, 21: 1-4. 10.1097\/MOU.0b013e32834100c9.","journal-title":"Curr Opin Urol"},{"key":"3595_CR16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.juro.2007.03.103","volume":"178","author":"JK Parsons","year":"2007","unstructured":"Parsons JK: Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems. J Urol. 2007, 178: 395-401. 10.1016\/j.juro.2007.03.103.","journal-title":"J Urol"},{"key":"3595_CR17","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/sj.pcan.4500221","volume":"1","author":"J Hammarsten","year":"1998","unstructured":"Hammarsten J, H\u00f6gstedt B, Holthuis N, Mellstr\u00f6m D: Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia. Prostate Cancer Prostatic Dis. 1998, 1: 157-162. 10.1038\/sj.pcan.4500221.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"3595_CR18","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.eururo.2006.05.040","volume":"51","author":"C Ozden","year":"2007","unstructured":"Ozden C, Ozdal OL, Urgancioglu G, Koyuncu H, Gokkaya S, Memis A: The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia. Eur Urol. 2007, 51: 199-203. 10.1016\/j.eururo.2006.05.040.","journal-title":"Eur Urol"},{"key":"3595_CR19","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","volume":"27","author":"S Wild","year":"2004","unstructured":"Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004, 27: 1047-1053. 10.2337\/diacare.27.5.1047.","journal-title":"Diabetes Care"},{"key":"3595_CR20","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1001\/jama.2009.726","volume":"301","author":"JC Chan","year":"2009","unstructured":"Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, Hu FB: Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009, 301: 2129-2140. 10.1001\/jama.2009.726.","journal-title":"JAMA"},{"key":"3595_CR21","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1007\/s00125-011-2171-z","volume":"54","author":"CH Tseng","year":"2011","unstructured":"Tseng CH: Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan. Diabetologia. 2011, 54: 2009-2015. 10.1007\/s00125-011-2171-z.","journal-title":"Diabetologia"},{"key":"3595_CR22","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1080\/07853890902729778","volume":"41","author":"CH Tseng","year":"2009","unstructured":"Tseng CH, Chong CK, Tseng CP, Chan TT: Age-related risk of mortality from bladder cancer in diabetic patients: a 12-year follow-up of a national cohort in Taiwan. Ann Med. 2009, 41: 371-379. 10.1080\/07853890902729778.","journal-title":"Ann Med"},{"key":"3595_CR23","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1007\/s00125-006-0468-0","volume":"49","author":"SC Larsson","year":"2006","unstructured":"Larsson SC, Orsini N, Brismar K, Wolk A: Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia. 2006, 49: 2819-2823. 10.1007\/s00125-006-0468-0.","journal-title":"Diabetologia"},{"key":"3595_CR24","doi-asserted-by":"publisher","first-page":"789174","DOI":"10.1155\/2012\/789174","volume":"2012","author":"B Arcidiacono","year":"2012","unstructured":"Arcidiacono B, Iiritano S, Nocera A, Possidente K, Nevolo MT, Ventura V, Foti D, Chiefari E, Brunetti A: Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms. Exp Diabetes Res. 2012, 2012: 789174-","journal-title":"Exp Diabetes Res"},{"key":"3595_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jfma.2011.10.003","volume":"111","author":"CH Tseng","year":"2012","unstructured":"Tseng CH: Pioglitazone and bladder cancer in human studies: is it diabetes itself, diabetes drugs, flawed analyses or different ethnicities?. J Formos Med Assoc. 2012, 111: 123-131. 10.1016\/j.jfma.2011.10.003.","journal-title":"J Formos Med Assoc"},{"key":"3595_CR26","doi-asserted-by":"publisher","first-page":"278","DOI":"10.2337\/dc11-1449","volume":"35","author":"CH Tseng","year":"2012","unstructured":"Tseng CH: Pioglitazone and bladder cancer: a population-based study of Taiwanese. Diabetes Care. 2012, 35: 278-280. 10.2337\/dc11-1449.","journal-title":"Diabetes Care"},{"key":"3595_CR27","doi-asserted-by":"publisher","first-page":"916","DOI":"10.2337\/dc10-1068","volume":"34","author":"JD Lewis","year":"2011","unstructured":"Lewis JD, Ferrara A, Peng T, Hedderson M, Bilker WB, Quesenberry CP, Vaughn DJ, Nessel L, Selby J, Strom BL: Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study. Diabetes Care. 2011, 34: 916-922. 10.2337\/dc10-1068.","journal-title":"Diabetes Care"},{"key":"3595_CR28","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1007\/s00125-012-2538-9","volume":"55","author":"A Neumann","year":"2012","unstructured":"Neumann A, Weill A, Ricordeau P, Fagot JP, Alla F, Allemand H: Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study. Diabetologia. 2012, 55: 1953-1962. 10.1007\/s00125-012-2538-9.","journal-title":"Diabetologia"},{"key":"3595_CR29","doi-asserted-by":"publisher","first-page":"616","DOI":"10.2337\/dc10-1640","volume":"34","author":"CH Tseng","year":"2011","unstructured":"Tseng CH: Diabetes and risk of prostate cancer: a study using the National Health Insurance. Diabetes Care. 2011, 34: 616-621. 10.2337\/dc10-1640.","journal-title":"Diabetes Care"},{"key":"3595_CR30","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1530\/EJE-12-0369","volume":"167","author":"CH Tseng","year":"2012","unstructured":"Tseng CH: Diabetes, metformin use, and colon cancer: a population-based cohort study in Taiwan. Eur J Endocrinol. 2012, 167: 409-416. 10.1530\/EJE-12-0369.","journal-title":"Eur J Endocrinol"},{"key":"3595_CR31","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1056\/NEJM199905063401803","volume":"340","author":"DS Michaud","year":"1999","unstructured":"Michaud DS, Spiegelman D, Clinton SK, Rimm EB, Curhan GC, Willett WC, Giovannucci EL: Fluid intake and the risk of bladder cancer in men. N Engl J Med. 1999, 340: 1390-1397. 10.1056\/NEJM199905063401803.","journal-title":"N Engl J Med"},{"key":"3595_CR32","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1002\/ijc.23711","volume":"123","author":"X Jiang","year":"2008","unstructured":"Jiang X, Castelao JE, Groshen S, Cortessis VK, Shibata DK, Conti DV, Gago-Dominguez M: Water intake and bladder cancer risk in Los Angeles County. Int J Cancer. 2008, 123: 1649-1656. 10.1002\/ijc.23711.","journal-title":"Int J Cancer"},{"key":"3595_CR33","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1111\/j.1523-1755.2005.00344.x","volume":"67","author":"AD Rule","year":"2005","unstructured":"Rule AD, Jacobson DJ, Roberts RO, Girman CJ, McGree ME, Lieber MM, Jacobsen SJ: The association between benign prostatic hyperplasia and chronic kidney disease in community-dwelling men. Kidney Int. 2005, 67: 2376-2382. 10.1111\/j.1523-1755.2005.00344.x.","journal-title":"Kidney Int"},{"key":"3595_CR34","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.urology.2007.11.140","volume":"71","author":"CH Chen","year":"2008","unstructured":"Chen CH, Shun CT, Huang KH, Huang CY, Yu HJ, Pu YS: Characteristics of female non-muscle-invasive bladder cancer in Taiwan: association with upper tract urothelial carcinoma and end-stage renal disease. Urology. 2008, 71: 1155-1160. 10.1016\/j.urology.2007.11.140.","journal-title":"Urology"},{"key":"3595_CR35","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/jnci\/93.10.783","volume":"93","author":"AW Hsing","year":"2001","unstructured":"Hsing AW, Chua S, Gao YT, Gentzschein E, Chang L, Deng J, Stanczyk FZ: Prostate cancer risk and serum levels of insulin and leptin: a population-based study. J Natl Cancer Inst. 2001, 93: 783-789. 10.1093\/jnci\/93.10.783.","journal-title":"J Natl Cancer Inst"},{"key":"3595_CR36","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/pros.10096","volume":"52","author":"AP Chokkalingam","year":"2002","unstructured":"Chokkalingam AP, Gao YT, Deng J, Stanczyk FZ, Sesterhenn IA, Mostofi FK, Fraumeni JF, Hsing AW: Insulin-like growth factors and risk of benign prostatic hyperplasia. Prostate. 2002, 52: 98-105. 10.1002\/pros.10096.","journal-title":"Prostate"},{"key":"3595_CR37","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1007\/s00125-006-0314-4","volume":"49","author":"CH Tseng","year":"2006","unstructured":"Tseng CH, Tseng CP, Chong CK, Huang TP, Song YM, Chou CW, Lai SM, Tai TY, Cheng JC: Increasing incidence of diagnosed type 2 diabetes in Taiwan: analysis of data from a national cohort. Diabetologia. 2006, 49: 1755-1760. 10.1007\/s00125-006-0314-4.","journal-title":"Diabetologia"},{"key":"3595_CR38","doi-asserted-by":"publisher","first-page":"18","DOI":"10.2174\/1876524600902010018","volume":"2","author":"CH Tseng","year":"2009","unstructured":"Tseng CH: The epidemiologic transition of diabetes mellitus in Taiwan: Implications for reversal of female preponderance from a national cohort. Open Diabetes Journal. 2009, 2: 18-23. 10.2174\/1876524600902010018.","journal-title":"Open Diabetes Journal"},{"key":"3595_CR39","unstructured":"US Food & Drug Administration, Endocrinologic & Metabolic Advisory Committee: Dapagliflozin (BMS-512148) EMDAC Background Document. http:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/Drugs\/EndocrinologicandMetabolicDrugsAdvisoryCommittee\/UCM262996.pdf (accessed 10 August 2011)"},{"key":"3595_CR40","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3322\/caac.20077","volume":"60","author":"BL Jacobs","year":"2010","unstructured":"Jacobs BL, Lee CT, Montie JE: Bladder cancer in 2010: how far have we come?. CA Cancer J Clin. 2010, 60: 244-272. 10.3322\/caac.20077.","journal-title":"CA Cancer J Clin"},{"key":"3595_CR41","doi-asserted-by":"publisher","first-page":"c143","DOI":"10.1159\/000315883","volume":"116","author":"KJ van Stralen","year":"2010","unstructured":"van Stralen KJ, Dekker FW, Zoccali C, Jager KJ: Confounding. Nephron Clin Pract. 2010, 116: c143-c147. 10.1159\/000315883.","journal-title":"Nephron Clin Pract"},{"key":"3595_CR42","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1377\/hlthaff.22.3.61","volume":"22","author":"TM Cheng","year":"2003","unstructured":"Cheng TM: Taiwan's new national health insurance program: genesis and experience so far. Health Aff (Millwood). 2003, 22: 61-76. 10.1377\/hlthaff.22.3.61.","journal-title":"Health Aff (Millwood)"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-13-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T19:55:52Z","timestamp":1468353352000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-13-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,4]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["3595"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-13-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,4]]},"article-number":"7"}}